Cargando…
Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study
OBJECTIVES: India introduced BBV152/Covaxin and AZD1222/Covishield vaccines in January 2021. We estimated the effectiveness of these vaccines against severe COVID-19 among individuals aged ≥45 years. METHODS: We did a multi-centric, hospital-based, case-control study between May and July 2021. Cases...
Ejemplares similares
-
A new approach to airway assessment—“Line of Sight” and more. Recommendations of the Task Force of Airway Management Foundation (AMF)
por: Kumar, Rakesh, et al.
Publicado: (2020) -
Curcuma oil ameliorates insulin resistance & associated thrombotic complications in hamster & rat
por: Singh, Vishal, et al.
Publicado: (2015) -
Predictors of Clinical Outcomes in Adult COVID-19 Patients Admitted to a Tertiary Care Hospital in India: an analytical cross-sectional study
por: Chauhan, Nishant Kumar, et al.
Publicado: (2021) -
A Clinico-Epidemiological Study of Scalp Hair Loss in Children (0–18 Years) in Kota Region, South-East Rajasthan
por: Sharma, Manoj Kumar, et al.
Publicado: (2019) -
Acute Rise in the Incidence of Chickenpox due to Temperature Variation in a Specific Locality of Gwalior City
por: Misra, Vaibhav, et al.
Publicado: (2021)